Tag: breast cancer
May 10, 2019
Genetic Technologies Completes Two Genetic Risk Tests for Colorectal and Breast Cancer
Genetic Technologies (NASDAQ:GENE, ASX:GTG), has announced two new cancer risk assessments, branded ‘GeneType for Colorectal Cancer’ and ‘GeneType for Breast... April 2, 2019
Hemispherx Announces First Participant Received Initial Dosing in Breast Cancer Clinical Trial
Hemispherx (NYSE American:HEB) has announced the active initiation of a clinical trial sponsored by Roswell Park Comprehensive Cancer Center, evaluating...
March 14, 2019
Atossa Genetics Soars on FDA Expanded Access Program Approval
Shares of Atossa Genetics were up over 368 percent on Thursday to close at US$7.07 following the approval from the...
July 3, 2018
4 Top Biotech Stocks on the TSX of Q2 2018
Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of...
May 23, 2018
Providing Non-Exclusive Licenses Makes Zymeworks “Lucky,” Says CEO
The Investing News Network spoke with Zymeworks CEO Ali Tehrani at the Bloom Burton & Co. Health Care Conference, which...
May 10, 2018
3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma
3D Signatures Inc. (TSXV:DXD,OTCQB:TDSGF), a personalized medicine company with a proprietary software platform (TeloViewTM) based on the three-dimensional analysis of... May 7, 2018